Kidney Disease
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Articles about Kidney Disease
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews Kidney Disease hub for FDA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Eli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases
Akebia Therapeutics Vadadustat Shows Significant Mortality Reduction in New Kidney Disease Analysis
FDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.